Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
149 studies found for:    "Rothmund-Thomson Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"Rothmund-Thomson Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Calcium Absorption in Patients With Rothmund-Thomson Syndrome
Condition: Rothmund-Thomson Syndrome
Intervention:
2 Terminated Peripheral Blood Biomarkers in Idiopathic Interstitial Pneumonias
Condition: Idiopathic Interstitial Pneumonias
Intervention:
3 Recruiting Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Condition: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions: Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
4 Recruiting A Linkage and Association Study in Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Familial Pulmonary Fibrosis;   Idiopathic Interstitial Pneumonia;   Familial Interstitial Pneumonia
Intervention:
5 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
6 Completed
Has Results
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
Conditions: Alveolitis, Fibrosing;   Fibrosis, Pulmonary;   Hypertension, Pulmonary
Intervention: Drug: sildenafil
7 Unknown  Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
Conditions: Emphysema;   Alveolitis, Fibrosing;   Cystic Fibrosis;   Bronchiectasis;   Lung Diseases
Intervention: Procedure: Pulmonary rehabilitation programme
8 Recruiting Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
9 Available Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: nintedanib
10 Recruiting Nandrolone Decanoate in the Treatment of Telomeropathies
Conditions: Aplastic Anemia;   Bone Marrow Failure Syndromes;   Idiopathic Pulmonary Fibrosis;   Telomere Shortening
Intervention: Drug: Nandrolone Decanoate
11 Active, not recruiting Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)
Condition: Pulmonary Fibrosis
Intervention: Drug: BIBF 1120
12 Recruiting Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention:
13 Recruiting Study in Subjects With PAH and PH Secondary to IPF Using Inhaled NITROsyl
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis
Intervention: Drug: Inhaled Nitric Oxide
14 Recruiting Long Term Effects of an Inpatient Pulmonary Rehabilitation Program in Patients With Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Procedure: Inpatient Rehabilitation
15 Recruiting A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Biological: Tralokinumab;   Other: Placebo
16 Completed The Occurence of Inflammation and Oxidative Stress in Lung Diseases
Conditions: Interstitial Lung Diseases;   Sarcoidosis;   Idiopathic Pulmonary Fibrosis;   COPD
Intervention:
17 Active, not recruiting A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis
Condition: Pulmonary Fibrosis
Intervention: Drug: aerosol interferon-gamma
18 Active, not recruiting Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Standard pulmonary rehabilitation program
19 Completed Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide
Conditions: Idiopathic Pulmonary Fibrosis;   Cough
Interventions: Drug: Thalidomide;   Drug: Placebo
20 Active, not recruiting Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: FG-3019

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years